These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14553873)
1. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Suissa S; Assimes T; Brassard P; Ernst P Am J Med; 2003 Oct; 115(5):377-81. PubMed ID: 14553873 [TBL] [Abstract][Full Text] [Related]
2. Low-dose inhaled corticosteroids and the prevention of death from asthma. Suissa S; Ernst P; Benayoun S; Baltzan M; Cai B N Engl J Med; 2000 Aug; 343(5):332-6. PubMed ID: 10922423 [TBL] [Abstract][Full Text] [Related]
3. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Blais L; Suissa S; Boivin JF; Ernst P Thorax; 1998 Dec; 53(12):1025-9. PubMed ID: 10195073 [TBL] [Abstract][Full Text] [Related]
4. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma. Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308 [TBL] [Abstract][Full Text] [Related]
5. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma. Ducharme FM; Hicks GC Cochrane Database Syst Rev; 2000; (3):CD002314. PubMed ID: 10908555 [TBL] [Abstract][Full Text] [Related]
6. Guidelines and realities of asthma management. The Philadelphia story. Lang DM; Sherman MS; Polansky M Arch Intern Med; 1997 Jun; 157(11):1193-200. PubMed ID: 9183230 [TBL] [Abstract][Full Text] [Related]
7. The association of asthma and atrial fibrillation--a nationwide population-based nested case-control study. Chan WL; Yang KP; Chao TF; Huang CC; Huang PH; Chen YC; Chen TJ; Lin SJ; Chen JW; Leu HB Int J Cardiol; 2014 Sep; 176(2):464-9. PubMed ID: 25127961 [TBL] [Abstract][Full Text] [Related]
8. Inhaled steroids and the risk of hospitalization for asthma. Donahue JG; Weiss ST; Livingston JM; Goetsch MA; Greineder DK; Platt R JAMA; 1997 Mar; 277(11):887-91. PubMed ID: 9062326 [TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Blais L; Ernst P; Boivin JF; Suissa S Am J Respir Crit Care Med; 1998 Jul; 158(1):126-32. PubMed ID: 9655718 [TBL] [Abstract][Full Text] [Related]
10. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Ng D; Salvio F; Hicks G Cochrane Database Syst Rev; 2004; (2):CD002314. PubMed ID: 15106175 [TBL] [Abstract][Full Text] [Related]
11. Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy. Blais L; Firoozi F; Kettani FZ; Ducharme FM; Lemière C; Beauchesne MF; Bérard A Pharmacotherapy; 2012 Mar; 32(3):202-9. PubMed ID: 22392453 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of asthma treatment in schoolchildren in NSW, Australia. Paterson NA; Peat JK; Mellis CM; Xuan W; Woolcock AJ Eur Respir J; 1997 Mar; 10(3):658-64. PubMed ID: 9073001 [TBL] [Abstract][Full Text] [Related]
13. Association Between Inhaled Corticosteroid Use and Bone Fracture in Children With Asthma. Gray N; Howard A; Zhu J; Feldman LY; To T JAMA Pediatr; 2018 Jan; 172(1):57-64. PubMed ID: 29131874 [TBL] [Abstract][Full Text] [Related]
14. Towards the optimal use of inhaled corticosteroid therapy in adult asthma. Shirtcliffe P; Holt S; Crane J; Beasley R N Z Med J; 2001 Jun; 114(1133):263-5. PubMed ID: 11453348 [No Abstract] [Full Text] [Related]
15. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Tattersfield AE; Town GI; Johnell O; Picado C; Aubier M; Braillon P; Karlström R Thorax; 2001 Apr; 56(4):272-8. PubMed ID: 11254817 [TBL] [Abstract][Full Text] [Related]
16. [Inhaled corticotherapy in asthma: when should it be started and how to stop?]. Aubier M Rev Pneumol Clin; 1996; 52(2):145-9. PubMed ID: 8761645 [TBL] [Abstract][Full Text] [Related]
17. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Busse WW; Middleton E; Storms W; Dockhorn RJ; Chu TJ; Grossman J; Weiler JM; Bronsky EA; Mansfield LE; Bell TD; Hemsworth GR; Perhach JL; D'Eletto TA; Dam A Am J Respir Crit Care Med; 1996 Jan; 153(1):122-7. PubMed ID: 8542104 [TBL] [Abstract][Full Text] [Related]
18. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
19. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Suissa S; Assimes T; Ernst P Thorax; 2003 Jan; 58(1):43-6. PubMed ID: 12511719 [TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]